Key result
A novel Southern blotting method detected junction fragments in 21 of 27 patients with DMD/BMD (77.8%), compared to 0% using conventional methods, enabling definitive carrier identification.
Why the study?
Does a novel Southern blotting method improve the detection of junction fragments in the dystrophin gene compared to conventional Southern blot in patients with DMD/BMD?
Does a novel Southern blotting method improve the detection of junction fragments in the dystrophin gene compared to conventional Southern blot in patients with DMD/BMD?
A novel Southern blotting method using rare cutting restriction endonucleases and single-stranded DNA electrophoresis improves the detection of dystrophin gene junction fragments for identifying DMD/BMD carriers.
May aid DMD/BMD carrier detection; leaves open validation in larger cohorts before practice change.
We developed a Southern blotting based method that uses rare cutting restriction endonucleases and electrophoresis of single stranded DNA to detect junction fragments resulting from the rearranged dystrophin gene. By conventional Southern blot hybridisation, no junction fragments were detected in 27 unrelated patients with Duchenne (DMD) or Becker (BMD) muscular dystrophy, who had 20 deletions and seven duplications in the dystrophin gene. With our new method, junction fragments were detected in 21 of these 27 patients. When the junction fragments were used as markers, five carriers were unequivocally diagnosed among six females from two families of DMD/ BMD patients. This novel method allows simple and definitive identification of carriers with risk factors for DMD/BMD without using quantitative Southern blot hybridisation.
No takes yet. Share an insight, caveat, or question.
Yamagishi et al. (1996) studied Duchenne (DMD) or Becker (BMD) muscular dystrophy (n=33). Novel Southern blotting method using rare cutting restriction endonucleases and single stranded DNA electrophoresis vs. Conventional Southern blot hybridisation was evaluated on Detection of junction fragments resulting from the rearranged dystrophin gene. A novel Southern blotting method detected junction fragments in 21 of 27 patients with DMD/BMD (77.8%), compared to 0% using conventional methods, enabling definitive carrier identification.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: